Get the latest news, insights, and market updates on CL (Colgate-Palmolive Company). Explore the news page 15 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
1 S&P 500 Stock with Promising Prospects and 2 Facing Challenges
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition. Dec 8, 2025 - $CL
Is Colgate-Palmolive Fairly Priced After Recent 3% Share Price Drop?
Wondering if Colgate-Palmolive at around $77 a share is still a safe staple or a quietly mispriced opportunity? You are not alone. This is exactly the kind of stock where valuation really matters. Over the last week the stock slipped about 3.0%, but it is still up 6.6% over three years, hinting at a slow growing compounder that investors rotate into and out of as sentiment shifts. Recently, the market has been weighing Colgate-Palmolive's push into higher margin oral care lines and... Dec 5, 2025 - $CL
1 Profitable Stock on Our Watchlist and 2 We Question
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. Dec 5, 2025 - $CL
Saudi Aramco cuts crude price to 5-year low
Investing.com -- Saudi Arabia has cut the price of its main crude grade to Asia to the lowest level in five years, as global oil markets continue to show signs of surplus. Dec 4, 2025 - $CL
1 Unpopular Stock That Should Get More Attention and 2 We Ignore
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory. Dec 2, 2025 - $CL
Looking at the Changing Narrative for Colgate-Palmolive After Analyst Downgrades and Growth Challenges
The consensus analyst price target for Colgate-Palmolive has edged down slightly to $87.21 from $87.26, reflecting marginally lower expectations in the near term. This update comes as expert sentiment incorporates both lingering challenges and signs of future recovery for the company. Stay tuned to discover how you can follow the evolving narrative and stay ahead of future updates on Colgate-Palmolive's outlook. Stay updated as the Fair Value for Colgate-Palmolive shifts by adding it to your... Dec 1, 2025 - $CL
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.